VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,164 | -78.4% | 5,965 | -79.6% | 0.00% | -81.8% |
| Q2 2023 | $958,941 | +117417.3% | 29,236 | +20.1% | 0.01% | -15.4% |
| Q1 2023 | $816 | -99.9% | 24,348 | +8.7% | 0.01% | -23.5% |
| Q3 2022 | $782,000 | +79.8% | 22,400 | -37.1% | 0.02% | +54.5% |
| Q2 2022 | $435,000 | – | 35,595 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,401,123 | $48,913,000 | 73.66% |
| venBio Partners LLC | 5,011,536 | $174,953,000 | 40.48% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $26,056,000 | 37.85% |
| Logos Global Management LP | 1,397,680 | $48,793,000 | 6.00% |
| Vivo Capital, LLC | 1,355,861 | $47,333,000 | 5.23% |
| Third Point | 4,312,834 | $150,561,000 | 2.72% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $6,284,000 | 2.71% |
| GREAT POINT PARTNERS LLC | 269,967 | $9,425,000 | 2.27% |
| Cormorant Asset Management, LP | 780,646 | $27,252,000 | 1.90% |
| Redmile Group, LLC | 1,365,000 | $47,652,000 | 1.85% |